Hadi Rezaeeyan

538 total citations
37 papers, 367 citations indexed

About

Hadi Rezaeeyan is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Hadi Rezaeeyan has authored 37 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Hadi Rezaeeyan's work include Platelet Disorders and Treatments (6 papers), MicroRNA in disease regulation (4 papers) and Blood groups and transfusion (4 papers). Hadi Rezaeeyan is often cited by papers focused on Platelet Disorders and Treatments (6 papers), MicroRNA in disease regulation (4 papers) and Blood groups and transfusion (4 papers). Hadi Rezaeeyan collaborates with scholars based in Iran, Canada and South Africa. Hadi Rezaeeyan's co-authors include Najmaldin Saki, Saeid Shahrabi, Habib Haybar, Mohammad Shahjahani, Trevor D. McKee, Fatemeh Javaherforooshzadeh, Habib Haybar, Seyedeh‐Nafiseh Hassani, Kaveh Jaseb and Ali Amin Asnafi and has published in prestigious journals such as Journal of Cellular Physiology, Apmis and Clinical Rheumatology.

In The Last Decade

Hadi Rezaeeyan

33 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadi Rezaeeyan Iran 12 115 91 64 62 62 37 367
Rong Guo China 13 191 1.7× 125 1.4× 65 1.0× 69 1.1× 104 1.7× 43 441
Rufeng Xie China 13 173 1.5× 178 2.0× 55 0.9× 61 1.0× 85 1.4× 30 496
Lin Liao China 11 80 0.7× 68 0.7× 37 0.6× 46 0.7× 37 0.6× 22 313
Jamie Robertson United Kingdom 5 130 1.1× 155 1.7× 23 0.4× 73 1.2× 76 1.2× 9 566
Pezhman Mirshahi France 12 173 1.5× 35 0.4× 94 1.5× 88 1.4× 55 0.9× 13 416
Shinya Nagasaka Japan 14 136 1.2× 104 1.1× 56 0.9× 37 0.6× 34 0.5× 24 486
Elizabeth A. McCart United States 12 114 1.0× 34 0.4× 38 0.6× 34 0.5× 39 0.6× 17 384
O. A. Antonova Russia 10 107 0.9× 66 0.7× 29 0.5× 32 0.5× 60 1.0× 30 297
Sho Sendo Japan 11 164 1.4× 167 1.8× 50 0.8× 62 1.0× 34 0.5× 37 515
Mario Witkowski Germany 7 240 2.1× 200 2.2× 77 1.2× 87 1.4× 33 0.5× 12 547

Countries citing papers authored by Hadi Rezaeeyan

Since Specialization
Citations

This map shows the geographic impact of Hadi Rezaeeyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadi Rezaeeyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadi Rezaeeyan more than expected).

Fields of papers citing papers by Hadi Rezaeeyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadi Rezaeeyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadi Rezaeeyan. The network helps show where Hadi Rezaeeyan may publish in the future.

Co-authorship network of co-authors of Hadi Rezaeeyan

This figure shows the co-authorship network connecting the top 25 collaborators of Hadi Rezaeeyan. A scholar is included among the top collaborators of Hadi Rezaeeyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadi Rezaeeyan. Hadi Rezaeeyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rezaeeyan, Hadi, et al.. (2025). When the victim becomes the villain: Platelets as drivers of immune dysregulation in ITP. Journal of Translational Autoimmunity. 11. 100309–100309.
3.
Hamblin, Michael R., et al.. (2025). Nanodrug-based modulation of platelet–leukocyte interactions in ovarian cancer: a new frontier in targeted therapy. Cancer Nanotechnology. 16(1). 3 indexed citations
4.
Rezaeeyan, Hadi, et al.. (2024). Evaluation of the hematological inflammatory parameters in the patients with immune thrombocytopenic purpura: A case–control study. Health Science Reports. 7(2). e1900–e1900. 2 indexed citations
5.
6.
Rezaeeyan, Hadi, et al.. (2023). Evaluation of common protein biomarkers involved in the pathogenesis of respiratory diseases with proteomic methods: A systematic review. Immunity Inflammation and Disease. 11(11). e1090–e1090. 4 indexed citations
7.
Rezaeeyan, Hadi, et al.. (2023). A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. BMC Medical Genomics. 16(1). 159–159. 3 indexed citations
8.
Rezaeeyan, Hadi, et al.. (2023). Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review. Iranian Journal of Public Health. 52(12). 2541–2553. 4 indexed citations
9.
10.
Javaherforooshzadeh, Fatemeh, et al.. (2020). The role of exogenous Fibrinogen in cardiac surgery: stop bleeding or induce cardiovascular disease. Molecular Biology Reports. 47(10). 8189–8198. 16 indexed citations
11.
Javaherforooshzadeh, Fatemeh, et al.. (2020). Do exosomes play role in cardiovascular disease development in hematological malignancy?. Molecular Biology Reports. 47(7). 5487–5493. 13 indexed citations
12.
Dargahi-Malamir, Mehrdad, et al.. (2020). Evaluation of Prognostic/Diagnostic Value of Hematological Markers in the Detection of Inflammation in Coronavirus Disease: A Review Study. Journal of Advances in Medical and Biomedical Research. 28(128). 171–174. 6 indexed citations
13.
Javaherforooshzadeh, Fatemeh, et al.. (2020). The role of molecular mechanism of Ten-Eleven Translocation2 (TET2) family proteins in pathogenesis of cardiovascular diseases (CVDs). Molecular Biology Reports. 47(7). 5503–5509. 14 indexed citations
14.
Haybar, Habib, et al.. (2019). Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia. Journal of Cellular Physiology. 234(9). 14500–14506. 30 indexed citations
15.
Rezaeeyan, Hadi, et al.. (2019). Cytogenetic and molecular assessment of childhood acute lymphoblastic leukemia patients from 2014 to 2017 in Ahvaz. Clinical Cancer Investigation Journal. 8(1). 28–28. 3 indexed citations
16.
Rajaei, Elham, Mohammad Taha Jalali, Seyed Mohammad Sadegh Pezeshki, et al.. (2019). Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran. Current Rheumatology Reviews. 16(2). 120–124. 4 indexed citations
17.
Asnafi, Ali Amin, et al.. (2019). Prognostic significance of mutated genes in megakaryocytic disorders. Oncology Reviews. 13(2). 408–408. 1 indexed citations
18.
Zayeri, Zeinab Deris, et al.. (2018). The effect of coagulation factors polymorphisms on abortion. Frontiers in Biology. 13(3). 190–196. 5 indexed citations
19.
Rezaeeyan, Hadi, et al.. (2018). Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach. Apmis. 126(5). 359–370. 20 indexed citations
20.
Rezaeeyan, Hadi, et al.. (2017). PD-1/PD-L1 as a prognostic factor in leukemia. Journal of Hematopathology. 10(1). 17–24. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rong Guo Breakdown of academic impact, for papers by Rufeng Xie Breakdown of academic impact, for papers by Lin Liao Breakdown of academic impact, for papers by Jamie Robertson Breakdown of academic impact, for papers by Pezhman Mirshahi Breakdown of academic impact, for papers by Shinya Nagasaka Breakdown of academic impact, for papers by Elizabeth A. McCart Breakdown of academic impact, for papers by O. A. Antonova Breakdown of academic impact, for papers by Sho Sendo Breakdown of academic impact, for papers by Mario Witkowski
Rankless by CCL
2026